Polyvalent vaccine against salmonid alphavirus infections

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/295 (2006.01) A61K 9/107 (2006.01) A61K 9/113 (2006.01) A61K 39/00 (2006.01) A61K 39/02 (2006.01) A61K 39/12 (2006.01) A61P 31/00 (2006.01) A61P 37/04 (2006.01) C12N 7/00 (2006.01) C07K 14/18 (2006.01)

Patent

CA 2653300

The present invention relates to a composition comprising salmonid alphavirus or an antigenic and/or immunogenic material derived thereof, combined with one or more components selected from the group consisting of: a live, attenuated or killed bacterium, a virus other than salmonid alphavirus, said virus preferably being attenuated or inactivated, a fungus, a parasite; and an antigenic and/or immunogenic material derived from any of these components. The invention further relates to a dosage form and a vaccine comprising the said composition and the invention provides for use of the composition in medicine. Also, the invention relates to a method of manufacturing a composition or a vaccine as described above, and to a method of improving a polyvalent vaccine, comprising including in the polyvalent vaccine an attenuated or inactivated salmonid alphavirus.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polyvalent vaccine against salmonid alphavirus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyvalent vaccine against salmonid alphavirus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyvalent vaccine against salmonid alphavirus infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1492921

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.